Search Result "FMS-Like tyrosin kinase 3 (FLT3) inhibitors"
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):
Small Molecule FLT3 Tyrosine Kinase Inhibitors
Ebook: Frontiers in Medicinal Chemistry
Volume: 3 Year: 2006
Author(s):
Doi: 10.2174/978160805206610603010399
Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1867-1883
Author(s): Dirk Schmidt-Arras, Joachim Schwable, Frank- D. Bohmer, Hubert Serve
Bench to Bedside Targeting of FLT3 in Acute Leukemia
Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 781-789
Author(s): Keith W. Pratz, Mark J. Levis
The Role of FLT3 Kinase as an AML Therapy Target
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2758-2765
Author(s): Michal Beffinger,Anna Skwarska
Targeting FLT3 Kinase in Acute Myelogenous Leukemia: Progress, Perils, and Prospects
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4 Issue: 3 Year: 2004 Page: 255-271
Author(s): Michael C. Heinrich
Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 2 Year: 2007 Page: 135-141
Author(s): Ryan J. Mattison, Kelly R. Ostler, Frederick L. Locke, Lucy A. Godley
Design of New Therapeutic Agents Targeting FLT3 Receptor Tyrosine Kinase Using Molecular Docking and 3D-QSAR Approach
Journal: Letters in Drug Design & Discovery
Volume: 17 Issue: 5 Year: 2020 Page: 585-596
Author(s): Swapnil Pandurang Bhujbal,Seketoulie Keretsu,Seung Joo Cho
Second-Generation Protein Kinase Inhibitor â A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003
Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 31-49
Author(s): Ugo Testa